Recruiting

Supportive Service Program

Sponsor:

Roswell Park Cancer Institute

Code:

NCT06833255

Conditions

Breast Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Interview

Questionnaire Administration

Support

Support Group Therapy

Study Details

Brief summary:

This clinical trial studies whether a post-treatment supportive service program can be used to help breast cancer survivors in Western New York (WNY) transition into post-treatment life (survivorship). The post-treatment supportive service program is delivered to breast cancer survivors of WNY. It combines group support sessions and one-on-one (1:1) peer mentoring sessions. The group support sessions include traditional support groups, educational topics/lessons, activities, such as cooking lessons, celebrations, or facility tours, and guest speakers. The 1:1 peer mentoring sessions are held with a long-term breast cancer survivor mentor. The long-term breast cancer survivor mentor helps the mentee get in the practice of performing once monthly self-assessments and create plans to help improve any identified modifiable risk factors. The long-term breast cancer survivor mentor can also help connect the mentee to providers or resources as needed. A post-treatment supportive service program may help Black women breast cancer survivors in WNY transition into survivorship.

Conditions

Breast Carcinoma

Study ID

NCT06833255

Start date

Apr 21, 2025

Status verified date

Nov, 2025

Completion date

Nov 30, 2030

Anticipated

Primary completion date

Mar 30, 2030

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Ability to speak and read English
  • At least 18 years of age or older
  • Live in the Western New York area
  • Has been diagnosed with breast cancer (any stage)
  • Has completed primary breast cancer treatments (i.e., systemic, radiation, and/or surgical interventions other than breast reconstruction surgeries)

  • Mentors are at least one-year post-treatment completion
  • Mentees are less than one-year post-treatment completion
  • Note: Individuals who have completed primary breast cancer treatments who are being managed with ongoing hormonal therapies and/or are awaiting breast reconstruction surgery may participate in this study (i.e., these therapies do not meet exclusion criteria)

  • Note: Although any breast cancer survivor may participate, priority will be given to those who have most recently transitioned into their post-treatment life (or those who report that support was either not offered or was unavailable to them during their less recent transition into post-treatment life) and /or self-identify as African American

Exclusion Criteria:

  • Currently receiving neoadjuvant and/or adjuvant systemic and/or radiations therapies
  • Unwilling or unable to complete the assessment in English
  • Are pregnant or nursing
  • Are unwilling or unable to follow protocol requirements

  • Note: Individuals who have completed primary breast cancer treatments who are being managed with ongoing hormonal therapies and/or are awaiting breast reconstruction surgery may participate in this study (i.e., these therapies do not meet exclusion criteria)

Study Design

Enrollment

125 participants

Anticipated

Intervention Model

Single group

Primary purpose

Health Services Research

Interventions and Outcome Measures

Arms

experimental: Health services research (survivorship support)

Patients attend survivorship group support sessions over 2 hours on the 1st and 3rd Thursday of each month and 1:1 peer mentoring sessions with long-term breast cancer survivors on the 2nd and 4th Thursday of each month for up to 12 months.

Interventions

Interview

Ancillary studies

Questionnaire Administration

Ancillary studies

Support

Attend 1:1 peer mentoring sessions

Support Group Therapy

Attend survivorship group support sessions

Primary outcome measure

  • Community-clinical linkages [ Time Frame: Up to 12 months ]
  • Facilitators to implementation [ Time Frame: At 6 and 12 months ]
  • Barriers to implementation [ Time Frame: At 6 and 12 months ]

Central Contacts and Locations

Locations

Roswell Park Cancer Institute

Recruiting

Buffalo, New York, United States, 14263

Contacts

Principal Investigator:

Julia Devonish

More Information

Sponsor

Roswell Park Cancer Institute

Last update posted

Nov 24, 2025

Last verified

Nov, 2025

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Roswell Park Cancer Institute on 2025-11-24.